ENERGI-F703
- Generic Name
- ENERGI-F703
ENERGI-F703 for Diabetic Foot Ulcers Phase II Study
Phase 2
Completed
- Conditions
- Diabetic FootFoot UlcerDiabetes MellitusWounds
- Interventions
- Drug: ENERGI-F703 matched vehicle
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Energenesis Biomedical Co., Ltd.
- Target Recruit Count
- 141
- Registration Number
- NCT02672436
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath